Online Only Articles

Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?

Hématologie Biologique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), France
Hématologie Biologique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), France
University of Florence, AOU Careggi, Hematology, Italy
University Hospital Carl Gustav Carus Dresden, Germany
Hématologie Biologique, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris (AP-HP), France
Università Cattolica Sacro Cuore, Roma, Italy
IUCT, Oncopole, Toulouse, France
Hôpital de Brabois, Nancy, France
Universita degli Studi di Firenze, Italy
IRCCS AOU San Martino-IST di Genova, Italy
University Hospital Carl Gustav Carus Dresden, Germany
Hôpital Cochin, Service d’hématologie, Paris, France
Hôpital Saint Louis, Service d’hématologie séniors, Paris, France
Hématologie Biologique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), France
CHU de Grenoble Alpes, Université Grenoble Alpes, Clinique Universitaire d’hématologie, Grenoble, France
Vol. 101 No. 7 (2016): July, 2016 https://doi.org/10.3324/haematol.2016.142695